載入...
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
BACKGROUND: In the PATHWAY-2 study of resistant hypertension, spironolactone reduced blood pressure substantially more than conventional antihypertensive drugs. We did three substudies to assess the mechanisms underlying this superiority and the pathogenesis of resistant hypertension. METHODS: PATHW...
Na minha lista:
| 發表在: | Lancet Diabetes Endocrinol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Lancet, Diabetes & Endocrinology
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5966620/ https://ncbi.nlm.nih.gov/pubmed/29655877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-8587(18)30071-8 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|